SCHEMBL13531985

SCHEMBL13531985

CCOC(C)C(=O)NC(C)NC(=O)CCN1C(=O)C=CC1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3A P49840 1/20 0.36
▸ GSK3B P49841 1/20 0.36
▸ PTGS1 P23219 7/20 0.36
▸ PTGS2 P35354 7/20 0.36
▸ MGLL Q99685 6/20 0.36
▸ FAAH O00519 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.34
▸ BLM P54132 2/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ WRN Q14191 1/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ FLT3 P36888 1/20 0.33
▸ AKT1 P31749 1/20 0.32
▸ BRPF1 P55201 1/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ FNTA P49354 1/20 0.32
▸ FNTB P49356 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13531986 0.92 GSK3A (0.33) GSK3AGSK3BPTGS1PTGS2MGLL
SCHEMBL14753568 0.86 POLB (0.32) CYP2C19AKT1
SCHEMBL18470748 0.86 HPGD (0.30) HPGD
SCHEMBL12414122 0.85 GSK3A (0.41) GSK3AGSK3BPTGS1PTGS2MGLL
SCHEMBL18470758 0.84 MEN1 (0.35) ALDH1A1MEN1KMT2ALMNA
SCHEMBL12412437 0.82 POLB (0.38) GSK3AGSK3BPTGS1PTGS2MGLL
SCHEMBL14870355 0.82 MGLL (0.39) GSK3AGSK3BPTGS1PTGS2MGLL
SCHEMBL10310592 0.81 AKT1 (0.34) AKT1
SCHEMBL12417471 0.81 POLB (0.35) GSK3AGSK3BPTGS1PTGS2MGLL
SCHEMBL12417512 0.79 GSK3A (0.31) GSK3AGSK3BPTGS1PTGS2MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180085468-A1 CONJUGATES OF AN IL-2 MOIETY AND A POLYMER NEKTAR THERAPEUTICS 2018-03-29 — — US disclosed
US-9861705-B2 Conjugates of an IL-2 moiety and a polymer NEKTAR THERAPEUTICS (US) 2018-01-09 — — US disclosed
US-20170035898-A1 CONJUGATES OF AN IL-15 MOIETY AND A POLYMER NEKTAR THERAPEUTICS 2017-02-09 — — US disclosed
US-9101670-B2 Conjugates of an anti-TNF-α antibody NEKTAR THERAPEUTICS (US) 2015-08-11 — — US disclosed
US-20140328791-A1 Conjugates of an IL-2 Moiety and a Polymer NEKTAR THERAPEUTICS 2014-11-06 — — US disclosed
US-20130059360-A1 POLYMER-BASED COMPOSITIONS AND CONJUGATES OF ANTIMICROBIAL AGENTS NEKTAR THERAPEUTICS (US) 2013-03-07 — — US disclosed
US-20100021481-A1 CONJUGATES OF AN ANTI-TNF-ALPHA ANTIBODY NEKTAR THERAPEUTICS (US) 2010-01-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140328791-A1 Conjugates of an IL-2 Moiety and a Polymer IL2, IL2RA, ILF2 GSK3A 4544/4885GSK3B 4627/4885PTGS1 724/4885
US-20100021481-A1 CONJUGATES OF AN ANTI-TNF-ALPHA ANTIBODY TNF, TNFRSF1A, TNFRSF9 GSK3A 3381/4885GSK3B 3928/4885PTGS1 427/4885
US-20180085468-A1 CONJUGATES OF AN IL-2 MOIETY AND A POLYMER IL2, IL2RA, ILF2 GSK3A 4533/4885GSK3B 4536/4885PTGS1 925/4885
US-20170035898-A1 CONJUGATES OF AN IL-15 MOIETY AND A POLYMER IL15, IL15RA, IL2 GSK3A 4171/4885GSK3B 4276/4885PTGS1 563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback